These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7127279)

  • 1. Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
    Shackney SE; Ford SS; Occhipinti SJ; Ritch PS; Riccardi R; Erickson BW
    Cancer Res; 1982 Nov; 42(11):4339-47. PubMed ID: 7127279
    [No Abstract]   [Full Text] [Related]  

  • 2. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal and sublethal effects of hydroxyurea in relation to drug concentration and duration of drug exposure in sarcoma 180 in vitro.
    Ford SS; Shackney SE
    Cancer Res; 1977 Aug; 37(8 Pt 1):2628-37. PubMed ID: 559543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
    Edelstein M; Vietti T; Valeriote F
    Cancer Res; 1974 Feb; 34(2):293-7. PubMed ID: 4810905
    [No Abstract]   [Full Text] [Related]  

  • 5. Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea.
    Mujagic H; Conger BM; Smith CA; Occhipinti SJ; Schuette WH; Shackney SE
    Cancer Res; 1983 Aug; 43(8):3598-603. PubMed ID: 6861132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine.
    Momparler RL
    Cancer Res; 1974 Aug; 34(8):1775-87. PubMed ID: 4526298
    [No Abstract]   [Full Text] [Related]  

  • 7. Mathematic models of cell synchrony and drug scheduling.
    Valleron Aj
    Cancer Treat Rep; 1976 Dec; 60(12):1899-911. PubMed ID: 1026345
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics.
    Ubezio P; Tagliabue G; Schechter B; Agur Z
    Cancer Res; 1994 Dec; 54(24):6446-51. PubMed ID: 7987841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoma 180 weight, DNA, and protein increase, depending on ARA-C schedule.
    Nencini P; Grassi MC
    Pharmacol Res Commun; 1976 Jun; 8(3):259-66. PubMed ID: 1026957
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hydroxyurea and cytarabine on rodent epidermal cells.
    Stoughton RB
    Arch Dermatol; 1971 Aug; 104(2):161-5. PubMed ID: 5093169
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between aberrant DNA replication and loss of cell viability in Chinese hamster ovary CHO-K1 cells.
    Woodcock DM; Adams JK; Cooper IA
    Cancer Res; 1982 Nov; 42(11):4744-52. PubMed ID: 7127310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and cytokinetic effects of 1-beta-D-arabinofuranosylcytosine, daunorubicin, and 6-thioguanine on HeLa cells in culture.
    Fried J; Perez AG; Doblin JM; Clarkson BD
    Cancer Res; 1981 Mar; 41(3):1127-32. PubMed ID: 7459856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedule dependency of anticancer effect of 1-beta-D-arabinofuranosylcytosine on rat ascites hepatomas.
    Abe I; Sato S; Watanabe M; Sato H
    Sci Rep Res Inst Tohoku Univ Med; 1978 Sep; 25(1-2):20-3. PubMed ID: 741221
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes.
    Inagaki A; Nakamura T; Wakisaka G
    Cancer Res; 1969 Dec; 29(12):2169-76. PubMed ID: 5392487
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT; Craig RW; Agarwal RP
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of arabinosylcytosine on cultured human lymphoma cells.
    Drewinko B; Ho DH; Barranco SC
    Cancer Res; 1972 Dec; 32(12):2737-42. PubMed ID: 4644206
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine.
    Liu B; Cui C; Duan W; Zhao M; Peng S; Wang L; Liu H; Cui G
    Eur J Med Chem; 2009 Sep; 44(9):3596-600. PubMed ID: 19321234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.
    Chou TC; Burchenal JH; Schmid FA; Braun TJ; Su TL; Watanabe KA; Fox JJ; Philips FS
    Cancer Res; 1982 Oct; 42(10):3957-63. PubMed ID: 7104996
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of 1- -D-arabinofuranosylcytosine-induced cell lethality.
    Karon M; Benedict WF; Rucker N
    Cancer Res; 1972 Dec; 32(12):2612-5. PubMed ID: 4674677
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
    Bergerat JP; Drewinko B; Corry P; Barlogie B; Ho DH
    Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.